Publications

Development of an RNA aptamer as a therapeutic agent for synucleinopathies

 44
Development of an RNA aptamer as a therapeutic agent for synucleinopathies

Tags:

Previous Article

Cognitive symptoms in cerebral palsy from remote network

Next Article

RNA aptamer to treat synucleinopathies

Related Posts

The 2024 Nobel Prize in Physiology or Medicine

The 2024 Nobel Prize in Physiology or Medicine

 124

Nuclear hormone-sensitive lipase regulates adipose tissue mass and adipocyte metabolism

Nuclear hormone-sensitive lipase regulates adipose tiss...

 77

A wrinkle in timers: evolutionary rewiring of conserved biological timekeepers

A wrinkle in timers: evolutionary rewiring of conserved...

 119